Vimarsana
Biggest News Aggregation in the World

Plasmab Discovery News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Plasmab Discovery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Plasmab Discovery Today - Breaking & Trending Today

Monash University Implements Antibody Discovery Application by Utilizing the Berkeley Lights Beacon® Platform - Vimarsana News

Monash University Implements Antibody Discovery Application by Utilizing the Berkeley Lights Beacon® Platform

/PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Monash University, one of Australia's leading...

Monash University Implements Antibody Discovery Application by Utilizing the Berkeley Lights Beacon® Platform - Vimarsana News

Monash University Implements Antibody Discovery Application by Utilizing the Berkeley Lights Beacon® Platform

/PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Monash University, one of Australia's leading...

Berkeley Lights to Showcase its Optofluidic Discovery - Vimarsana News

Berkeley Lights to Showcase its Optofluidic Discovery

EMERYVILLE, Calif., March 04, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its...

Berkeley Lights, Inc: Berkeley Lights Launches Opto Plasma B Discovery 4.0 to Accelerate Therapeutic Antibody Discovery Against Difficult Targets - Vimarsana News

Berkeley Lights, Inc: Berkeley Lights Launches Opto Plasma B Discovery 4.0 to Accelerate Therapeutic Antibody Discovery Against Difficult Targets

(2) EMERYVILLE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the Opto Plasma B Discovery 4.0 workflow. Opto Plasma B Discovery 4.0 is the industry's premier antibody discovery workflow by advancing from B cells to lead molecules in just 1 week. This workflow enables our customers to: Sample 4x more of the relevant biodiversity, screening up to 100,000 cells Functionally test with highly sensitive cell-based assays Recover not only sequences, but also re-expressed molecules without requiring costly gene synth...